The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, November 25, 2019
Mitsubishi Tanabe Pharma America announced the initiation of a global Phase 3 study evaluating an investigational oral suspension formulation of ...
read more
Friday, November 22, 2019
The FDA approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults.
read more
Thursday, November 21, 2019
Seelos announced the FDA has granted Fast Track designation to its new intranasal racemic ketamine program for the treatment of Acute Suicidal ...
read more
Wednesday, November 20, 2019
Dicerna and Novo Nordisk announced an agreement to discover and develop novel therapies for the treatment of liver-related cardio-metabolic diseases ...
read more
Wednesday, November 20, 2019
The FDA has granted accelerated approval to zanubrutinib for adult patients with mantle cell lymphoma who have received at least one prior therapy.
read more
Tuesday, November 19, 2019
The FDA approved Fetroja, an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections.
read more
Tuesday, November 19, 2019
Tarsius Pharma announced the EMA approved the designation of orphan drug for its TRS for treatment of non-infectious uveitis and has acknowledged the ...
read more
Monday, November 18, 2019
OWC Pharmaceutical and STENOCARE have signed a strategic MoU to develop and commercialize new cannabis-based medical products.
read more
Monday, November 18, 2019
The FDA granted accelerated approval to Brukinsa capsules for the treatment of adult patients with mantle cell lymphoma who have received at least one...
read more
Friday, November 15, 2019
VistaGen announced topline results from the ELEVATE study, a Phase 2 study of AV-101, its NMDA receptor glycine site antagonist, as an adjunctive ...
read more
Thursday, November 14, 2019
AstraZeneca Pharmaceuticals, Merck & Co
The FDA has accepted a NDA and granted Priority Review for selumetinib as a potential new medicine for pediatric patients aged three years and older ...
read more
Thursday, November 14, 2019
Immutep announced the grant of patent no. 3116909 entitled “Antibody molecules to LAG-3 and uses thereof” by the European Patent Office.
read more
Wednesday, November 13, 2019
Supernus has submitted a NDA to the FDA for SPN-812 for the treatment of patients with ADHD.
read more
Wednesday, November 13, 2019
Avanir will continue the clinical development program of AVP-786 for the treatment of agitation in patients with Alzheimer's dementia.
read more
Tuesday, November 12, 2019
PTC Therapeutics has announced positive results from part 2 of SUNFISH demonstrating that the study met its primary endpoint of change from baseline ...
read more